Coya Therapeutics (NASDAQ:COYA) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.34) by 17.65 percent. This is a 22.22 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $243.745 thousand which beat the analyst consensus estimate of $100.000 thousand by 143.74 percent. This is a 48.97 percent increase over sales of $163.616 thousand the same period last year.